ELOVL7 and Parkinson disease: It will be important to examine a broad range of PD-linked gene mutations and polymorphisms for which these candidate therapeutics could be applicable, including those “indirectly” impacting FA homeostasis, such as mutations in αS, as well as those PD genetic risk factors “directly” impacting FA equilibrium in their role in lipid metabolism, e.g., DGKQ and ELOVL7.